Health
Lawsuits Mount Over GLP-1 Eye Risk, Though Causation Remains Unclear
Ongoing litigation claims GLP-1 drugs cause blindness, but medical groups and manufacturers say evidence of direct causation is lacking.
Ongoing litigation claims GLP-1 drugs cause blindness, but medical groups and manufacturers say evidence of direct causation is lacking.